HCW Biologics Analyst Price Targets

Wall Street analyst price targets and consensus rating for HCW Biologics (HCWB).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$30Upside to Avg. PT+1871.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 28, 2026	Maxim Group	Michael Okunewitch	PT Raise	Buy	$2→$5
May 29, 2025	Maxim Group	Michael Okunewitch	PT Cut	Buy	$120→$35

Analyst Ratings News

PRO
Maxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5

Maxim Group analyst Michael Okunewitch maintains HCW Biologics (NASDAQ:HCWB) with a Buy and raises the price target from $2 to $5.

Benzinga Newsdesk

PRO
Maxim Group Maintains Buy on HCW Biologics, Lowers Price Target to $35

Maxim Group analyst Michael Okunewitch maintains HCW Biologics (NASDAQ:HCWB) with a Buy and lowers the price target from $120 to $35.

Benzinga Newsdesk

PRO
EF Hutton Assumes HCW Biologics at Buy, Announces Price Target of $9

EF Hutton analyst Tony Butler assumes HCW Biologics (NASDAQ:HCWB) with a Buy rating and announces Price Target of $9.

Benzinga Newsdesk

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

EF Hutton analyst Constantine Davides reiterates HCW Biologics (NASDAQ:HCWB) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

EF Hutton analyst Constantine Davides reiterates HCW Biologics (NASDAQ:HCWB) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

EF Hutton analyst Constantine Davides reiterates HCW Biologics (NASDAQ:HCWB) with a Buy and maintains $9 price target.

Benzinga Newsdesk

HCW Biologics Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

HCW Biologics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Maxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5

PRO
Maxim Group Maintains Buy on HCW Biologics, Lowers Price Target to $35

PRO
EF Hutton Assumes HCW Biologics at Buy, Announces Price Target of $9

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

People Also Watch

People Also Watch

HCW Biologics Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

HCW Biologics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROMaxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5

PROMaxim Group Maintains Buy on HCW Biologics, Lowers Price Target to $35

PROEF Hutton Assumes HCW Biologics at Buy, Announces Price Target of $9

PROEF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PROEF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PROEF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

People Also Watch

People Also Watch

PRO
Maxim Group Maintains Buy on HCW Biologics, Raises Price Target to $5

PRO
Maxim Group Maintains Buy on HCW Biologics, Lowers Price Target to $35

PRO
EF Hutton Assumes HCW Biologics at Buy, Announces Price Target of $9

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target

PRO
EF Hutton Reiterates Buy on HCW Biologics, Maintains $9 Price Target